Botox refers to Botulinum Toxins, a protein which is produced by Gram-positive, spore forming bacterium Clostridium Botulinum. Botulinum toxin is a potent neurotoxin protein that inhibits signal conduction to the neuromuscular endplate. The toxin acts directly on the neuromuscular endplate and other cholinergic synapses where it inhibits the release of neurotransmitter acetylcholine, leading to muscular paralysis of the affected fiber and loss of target organ function. Limited and diluted amounts of botulinum toxin is used for treating several therapeutic indications such as cervical dystonia, lazy eye, muscle contractures, hyperhidrosis, chronic migraine and bladder dysfunction among others. There are seven serologically distinct types of botulinum toxin such as A, B, C1, D, E, F, and G. Botulinum toxin types A and B are commonly used in medical preparations for treatment of muscle spasms.
Market Industry Reports (MIR) has published a new report titled "Botox Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global botox market is estimated to be over US$ 4800 million in 2019. It is anticipated to grow at 7.5% CAGR from 2019 to 2030.
Major Key Players of the Botox Market are:
Allergan, Ipsen Group, Medytox, Merz Pharma, HUGEL, US WorldMeds, Galderma Laboratories, L.P., Revance Therapeutics, Inc, Eisai Co., Ltd. and DAEWOONG CO.LTD among others.
Read More @ http://www.sbwire.com/press-releases/botox-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-allergan-ipsen-group-medytox-1281767.htm
Increasing inclination towards cosmetic procedures for several aesthetic treatments, growing adoption rate by geriatric individuals, and rising preference of minimally invasive & noninvasive aesthetic procedures are anticipated to boost the growth of botox market over the forecast period. Moreover, extensive research & development and awareness programs conducted by major companies across the globe for introducing new botox products is expected to contribute in increasing use of botox injections for several non-surgical cosmetic procedures. For instance, in June 2019; Evolus, Inc. launched #NEWTOX NOW consumer conversion program for rapid adoption of Jeuveau. It is a purified botulinum toxin type A formulation used for the temporary improvement in appearance of moderate to severe glabellar lines in adults.
According to American Society of Plastic Surgeons (ASPS), in 2018, there were more than 17.7 million surgical and minimally-invasive cosmetic procedures performed in the United States. In 2018, 15.9 million cosmetic minimally-invasive procedures were performed, out of which 7.44 million procedures used botulinum toxin type A during procedure. There has been rise of 4% for the use of botulinum toxin type A since 2017. Hence, the increasing preference of cosmetic minimally-invasive procedures with the application of botulinum toxin, in several developed and developing regions aid in substantial growth of the botox market.
Major Types of Botox Market covered are:
Botulinum Toxin Type A
Botulinum Toxin Type B
Major Applications of Botox Market covered are:
Aesthetics
Therapeutics
Read More @ http://www.sbwire.com/press-releases/botox-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-allergan-ipsen-group-medytox-1281767.htm
Market Industry Reports (MIR) has published a new report titled "Botox Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030." According to the report, the global botox market is estimated to be over US$ 4800 million in 2019. It is anticipated to grow at 7.5% CAGR from 2019 to 2030.
Major Key Players of the Botox Market are:
Allergan, Ipsen Group, Medytox, Merz Pharma, HUGEL, US WorldMeds, Galderma Laboratories, L.P., Revance Therapeutics, Inc, Eisai Co., Ltd. and DAEWOONG CO.LTD among others.
Read More @ http://www.sbwire.com/press-releases/botox-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-allergan-ipsen-group-medytox-1281767.htm
Increasing inclination towards cosmetic procedures for several aesthetic treatments, growing adoption rate by geriatric individuals, and rising preference of minimally invasive & noninvasive aesthetic procedures are anticipated to boost the growth of botox market over the forecast period. Moreover, extensive research & development and awareness programs conducted by major companies across the globe for introducing new botox products is expected to contribute in increasing use of botox injections for several non-surgical cosmetic procedures. For instance, in June 2019; Evolus, Inc. launched #NEWTOX NOW consumer conversion program for rapid adoption of Jeuveau. It is a purified botulinum toxin type A formulation used for the temporary improvement in appearance of moderate to severe glabellar lines in adults.
According to American Society of Plastic Surgeons (ASPS), in 2018, there were more than 17.7 million surgical and minimally-invasive cosmetic procedures performed in the United States. In 2018, 15.9 million cosmetic minimally-invasive procedures were performed, out of which 7.44 million procedures used botulinum toxin type A during procedure. There has been rise of 4% for the use of botulinum toxin type A since 2017. Hence, the increasing preference of cosmetic minimally-invasive procedures with the application of botulinum toxin, in several developed and developing regions aid in substantial growth of the botox market.
Major Types of Botox Market covered are:
Botulinum Toxin Type A
Botulinum Toxin Type B
Major Applications of Botox Market covered are:
Aesthetics
Therapeutics
Read More @ http://www.sbwire.com/press-releases/botox-market-to-witness-huge-growth-from-2019-2030-and-focusing-on-top-key-players-allergan-ipsen-group-medytox-1281767.htm
No comments:
Post a Comment